Historias de Pacientes
Your Guide to Pancreatitis Research and Trials
In this webinar, Joshua Henderson, Mission: Cure’s Chief Cure Strategy Officer, breaks down the current landscape of pancreatitis research and treatment development, including how many potential treatments Mission: Cure is tracking in its drug development pipeline. He also explores the vital role patients and caregivers play in helping move research forward.
Ionis announces FDA approval of a treatment for severe hypertriglyceridemia (sHTG)
On June 24, 2026, Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration approved TRYNGOLZA (Olezarsen) to lower triglycerides and reduce the risk of acute pancreatitis in adults with severe hypertriglyceridemia.
Living with Autoimmune Pancreatitis: Theresa’s IgG4-Related Disease Story
Theresa shares her 5-year journey with Type 1 Autoimmune Pancreatitis (IgG4-related disease), from a near misdiagnosis of cancer to now, a newly FDA-approved treatment for IgG4RD. Hear her story.